FTXHvsRSPHETF Comparison
VS
First Trust Nasdaq Pharmaceuticals ETF (FTXH) and Invesco S&P 500® Equal Weight Health Care ETF (RSPH) belong to the same industry segment: US Health Care. FTXH's top 1 sector exposures are Healthcare. In contrast, RSPH's top sector exposures are Healthcare and Consumer Non-Cyclicals. FTXH is more expensive with a Total Expense Ratio (TER) of 0.6%, versus 0.4% for RSPH. FTXH is up 33.54% year-to-date (YTD) with +$1.02B in YTD flows. RSPH performs worse with 26.78% YTD performance, and +$58M in YTD flows. Run a side-by-side ETF comparison of FTXH and RSPH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
FTXH vs RSPH performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 10/29/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | FTXH RSPH | +4.91%+7.41% | +11.28%+14.32% | +33.54%+26.78% | +50.09%+33.09% | +89.81%+62.13% | +77.86%+34.89% |
| Flows | FTXH RSPH | +$48M+$43M | +$135M+$101M | +$1.02B+$58M | +$1.03B+$55M | +$1.02B-$226M | +$1.02B-$209M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | FTXH RSPH | +18.83%+18.14% | +17.65%+16.81% | +17.12%+15.92% | +16.43%+16.80% |
| Max drawdown | FTXH RSPH | -5.45%-5.57% | -7.50%-10.87% | -19.32%-16.96% | -19.32%-21.91% |
| Max drawdown duration | FTXH RSPH | 57d55d | 99d116d | 393d434d | 393d817d |
Trading data
FTXH | RSPH | |
Last sale 10/30/2026 at 1:30 PM | $44.19 | $39.69 |
| Previous close 10/29/2026 | $43.77 | $40.14 |
| Consolidated volume 10/29/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of September 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
FTXH | RSPH | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 10/30/2026 at 1:30 PM
Live
Closed
FTXH | RSPH | |
|---|---|---|
| Last price | $44.19 | $39.69 |
| 1D performance | +0.96% | -1.12% |
| AuM | $1.18 B | $991.67 M |
| E/R | 0.6% | 0.4% |
Characteristics
FTXH | RSPH | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | First Trust | Invesco |
| Benchmark | NASDAQ US Smart Pharmaceuticals Index | S&P 500 Equal Weight Health Care Index |
| N° of holdings | 50 | 60 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | September 20, 2016 | November 1, 2006 |
| ESG | No | No |
Advertisement
Exposure
Countries
FTXH
USA
96.23%
Other
3.77%
RSPH
USA
96.84%
Other
3.16%
Sectors
FTXH
Healthcare
99.88%
Other
0.12%
RSPH
Healthcare
98.51%
Other
1.49%
Advertisement
Diversification
FTXH
Total weight of top 15 holdings out of 15
70.94%
RSPH
Total weight of top 15 holdings out of 15
28.14%
Top 15 holdings
Data as of September 30, 2026
FTXH
AbbVie, Inc.
7.37%
Eli Lilly & Co.
7.22%
Pfizer Inc.
7.18%
Johnson & Johnson
7.07%
Merck & Co., Inc.
7.07%
Viatris, Inc.
3.84%
Biogen, Inc.
3.74%
Gilead Sciences, Inc.
3.66%
United Therapeutics Corp.
3.61%
Amgen, Inc.
3.44%
Incyte Corp.
3.42%
Vertex Pharmaceuticals, Inc.
3.38%
Regeneron Pharmaceuticals, Inc.
3.34%
Bristol Myers Squibb Co.
3.34%
Zoetis, Inc.
3.26%
RSPH
Moderna, Inc.
2.35%
Illumina, Inc.
2.14%
Revvity, Inc.
1.97%
Agilent Technologies, Inc.
1.96%
Mettler-Toledo International, Inc.
1.94%
Intuitive Surgical, Inc.
1.90%
Thermo Fisher Scientific, Inc.
1.81%
West Pharmaceutical Services, Inc.
1.80%
Danaher Corp.
1.79%
Viatris, Inc.
1.79%
Waters Corp.
1.77%
Biogen, Inc.
1.75%
Veeva Systems, Inc.
1.74%
Amgen, Inc.
1.73%
AbbVie, Inc.
1.71%
Frequently asked questions about FTXH and RSPH
How have the FTXH and RSPH ETFs performed in 2026?
As of October 29, 2026, FTXH is up 33.54% year-to-date (YTD), while RSPH has returned 26.78%. That puts FTXH better performer ahead so far this year.
Which ETF is attracting more investor money: FTXH or RSPH?
Year-to-date, the FTXH ETF saw +$1.02B in flows, compared to +$58M for RSPH.
Which ETF is more volatile: FTXH or RSPH?
Over the past year, FTXH had a volatility of 17.65%, while RSPH experienced 16.81%.
Which ETF is bigger: FTXH or RSPH?
As of October 29, 2026, FTXH holds $1.18 B in assets under management (AUM), while RSPH manages $991.67 M.
What sectors do the FTXH and RSPH ETFs invest in?
FTXH leans toward sectors like Healthcare. Meanwhile, RSPH focuses on Healthcare.
What are the top holdings of the FTXH ETF and RSPH ETF?
FTXH top holdings include AbbVie, Inc., Eli Lilly & Co. and Pfizer Inc.. RSPH holds in its top three: Moderna, Inc., Illumina, Inc. and Revvity, Inc..
Which ETF is more diversified: FTXH or RSPH?
FTXH holds 50 securities with 70.94% of its assets in the top 15. RSPH has 60 securities and a top 15 weight of 28.14%.
Advertisement
Latest news about FTXH & RSPH
Advertisement
